⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14307127 | 0.98 | SMN1; SMN2 (0.46) | — | |
| Bromide SCHEMBL31267150 | 0.98 | ALDH1A1 (0.46) | — | |
| Ammonia Solution, Strong SCHEMBL6793670 | 0.98 | ALDH1A1 (0.46) | — | |
| SCHEMBL12569372 | 0.98 | SMN1; SMN2 (0.46) | — | |
| Iodide SCHEMBL31267157 | 0.98 | ALDH1A1 (0.46) | — | |
| Hydrochloric Acid SCHEMBL1241910 | 0.98 | ALDH1A1 (0.46) | — | |
| SCHEMBL12569379 | 0.93 | — | — | |
| SCHEMBL18652395 | 0.86 | ALDH1A1 (0.44) | — | |
| SCHEMBL26027168 | 0.85 | SMN1; SMN2 (0.44) | — | |
| SCHEMBL8356970 | 0.82 | ALDH1A1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195631-A1 | ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER | UNIVERSITY OF MASSACHUSETTS | 2025-06-19 | — | — | US | claimed |
| CN-120047639-A | Method for rapidly generating geological survey basic map | 河北省地质调查院(河北省碳中和地学研究中心) | 2025-05-27 | — | — | CN | claimed |
| CN-120000814-A | Nerve center regulation experimental method for general anesthesia arousal and mental rewarding side effect | 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） | 2025-05-16 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| EP-4499805-A1 | ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER | University Of Massachusetts (US) | 2025-02-05 | — | — | EP | claimed |
| CN-119143621-A | Method for preparing N- (2- (cyclohex-1-en-1-yl) ethyl) -2-p-methoxyphenyl acetamide | 江苏恩华药业股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-119072202-A | Surface treatment method for improving photoelectric property of perovskite | 上海交通大学 | 2024-12-03 | — | — | CN | claimed |
| CN-118016161-A | Synovitis biomarker screening analysis method for targeting iron death and lipid metabolism | 莆田学院附属医院（莆田市第二医院） | 2024-05-10 | — | — | CN | claimed |
| WO-2024096484-A1 | BIOMARKER FOR DETECTING FOOD POISONING BACTERIA BY USING NEXT-GENERATION SEQUENCING, AND METHOD FOR DETECTING FOOD POISONING BACTERIA BY USING SAME | 대한민국(식품의약품안전처장) | 2024-05-10 | — | — | WO | claimed |
| US-20240115671-A1 | INTRACELLULAR DELIVERY OF THERAPEUTIC PROTEINS DESIGNED TO INVADE AND AUTONOMOUSLY LYSE AND METHODS OF USE THEREOF | UNIV MASSACHUSETTS (US) | 2024-04-11 | — | — | US | claimed |
| WO-2004089416-A2 | COMBINATION OF AN 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND AN ANTIHYPERTENSIVE AGENT | NOVO NORDISK A/S (DK) | 2004-10-21 | — | — | WO | claimed |
| WO-2004089470-A2 | NEW AMIDE DERIVATIVES AND PHARMACEUTICAL USE THEREOF | NOVO NORDISK A/S (DK) | 2004-10-21 | — | — | WO | claimed |
| WO-2004089415-A2 | COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST | NOVO NORDISK A/S (DK) | 2004-10-21 | — | — | WO | claimed |
| EP-1420021-A1 | DNA Methyltransferase inhibitors | The Penn State Research Foundation (US) | 2004-05-19 | — | — | EP | claimed |
| JP-2003501431-A | — | — | 2003-01-14 | — | — | JP | claimed |
| WO-2002059177-A2 | POLY (HYDROXYAMINOETHERS) HAVING A LOW CHLORIDE CONTENT | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-08-01 | — | — | WO | claimed |
| EP-1181291-A2 | DNA METHYLTRANSFERASE INHIBITORS | THE PENN STATE RESEARCH FOUNDATION (US) | 2002-02-27 | — | — | EP | claimed |
| WO-2000075142-A2 | DNA METHYLTRANSFERASE INHIBITORS | THE PENN STATE RESEARCH FOUNDATION (US) | 2000-12-14 | — | — | WO | claimed |
| EP-0623586-B1 | Process for the preparation of 2-(1-cyclohexenyl)ethylamine | LONZA AG (CH) | 1996-04-03 | — | — | EP | claimed |
| EP-0623586-A1 | Process for the preparation of 2-(1-cyclohexenyl)ethylamine | LONZA AG (CH) | 1994-11-09 | — | — | EP | claimed |